Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

KUCHING: Asean must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV patients in their respective countries, says Datuk Lukanisman Awang Sauni.

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

KUCHING: Asean member states must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Findings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...

Joint venture between GlaxoSmithKline and Pfizer in HIV illustrates opportunities to develop combination pills to challenge current market leaders.

The company announced that the US FDA approved Yeztugo ® (lenacapavir), Gilead Sciences, Inc. (NASDAQ:GILD)’s injectable HIV-1 capsid inhibitor, as pre-exposure prophylaxis (PrEP) in order to ...

The Affordable Care Act will continue to provide free preventative medications to millions of people who rely on that provision of the law.